Journal Guide

Logic has found application in virtually all aspects of Information Technology, from software engineering and hardware to programming and artificial intelligence. Indeed, logic, artificial intelligence and theoretical computing are influencing each other to the extent that a new interdisciplinary area of Logic and Computation is emerging.The Journal of Logic and Computation aims to promote the growth of logic and computing, including, among others, the following areas of interest: Logical Systems, such as classical and non-classical logic, constructive logic, categorical logic, modal logic, type theory, feasible maths.... Logical issues in logic programming, knowledge-based systems and automated reasoning; logical issues in knowledge representation, such as non-monotonic reasoning and systems of knowledge and belief; logics and semantics of programming; specification and verification of programs and systems; applications of logic in hardware and VLSI, natural language, cincurrent computation, planning, and databases. The bulk of the content is technical scientific papers, although letters, reviews, and discussions, as well as relevant conference reviews, are included.

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.The subject material appropriate for submission includes:• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.• Agents that activate genes or modify transcription and translation within the immune response.• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.• Production, function and regulation of cytokines and their receptors.• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions. • Studies on the nature and function of drug and hormone receptors on lymphocytes and other cells in the immune system.• Studies of cell-derived or humoral factors that modify the immune system causing cytotoxicity, inducing antibody production and mediating inflammatory responses.• The development of immunologically based assays and their application to disease, including assays for drugs, hormones, cyclic nucleotides, tumor antigens, etc.• The Editors will be pleased to receive published books for possible independent review.Please Bookmark this URL: http://www.elsevier.com/locate/intimpThese Backfiles include Immunopharmacology and the International Journal of Immunopharmacology.

International Journal of Inflammation is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of inflammation.

This review journal provides the most current information on basic and translational research in immunology and related fields. In addition to invited reviews, the journal accepts for publication articles and editorials on relevant topics proposed by contributors. Each issue of International Reviews of Immunology contains both solicited and unsolicited review articles, editorials, and 'In-this-Issue' highlights. The journal also hosts reviews that position the authors' original work relative to advances in a given field, bridging the gap between annual reviews and the original research articles.This review series is relevant to all immunologists, molecular biologists, microbiologists, translational scientists, industry researchers, and physicians who work in basic and clinical immunology, inflammatory and allergic diseases, vaccines, and additional topics relevant to medical research and drug development that connect immunology to disciplines such as oncology, cardiovascular disease, and metabolic disorders.Covered in International Reviews of Immunology:1) Basic and developmental immunology (innate and adaptive immunity; inflammation; and tumor and microbial immunology);2) Clinical research (mechanisms of disease in man pertaining to infectious diseases, autoimmunity, allergy, oncology / immunology); and3) Translational research (relevant to biomarkers, diagnostics, vaccines, and drug development).The editors' intent is that this journal provide the most recent and relevant information, hence the submissions are being reviewed by members of the editorial team and / or experts in the field; yet the turnaround time is short, in order to insure that the reviews contain the latest data. An international board of editors makes sure that the material presented is as broad as possible, both in terms of the geographic distribution of contributors and the range of interests represented.Read More: http://informahealthcare.com/page/iri/Description.

The Iranian Journal of Immunology (I.J.I) is an internationally disseminated peer-reviewed publication andpublishes a broad range of experimental and theoretical studies concerned with all aspects of immunology.

Journal for ImmunoTherapy of Cancer is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.The journal welcomes submissions in the following areas and other related topics:Basic Tumor ImmunologyTumor antigens, innate and adaptive anti-tumor immune mechanisms, immune regulation, immune response, cancer and inflammation, preclinical models, chemotherapy and radiotherapy interactions with the anti-tumor immune responseClinical/Translational Cancer ImmunotherapyFirst-in-man clinical trials, phase II/III clinical studies, immune monitoring investigations, tumor microenvironment, host genetics and clinical outcomeImmunotherapy BiomarkersPredictive/prognostic biomarker studies, gene expression studies in cancer immunotherapy, serological immune biomarkers, multiparameter flow cytometry-defined immune biomarkers, high content immunohistological studiesReviews/EditorialsTriggering discussion on hot topics and innovative concepts

Journal for ImmunoTherapy of Cancer is the official journal of the Society for Immunotherapy of Cancer (SITC). The Society for Immunotherapy of Cancer (SITC) is a 501 (c)(3) non-profit society of medical professionals that was established in 1984 to exchange, encourage and promote information about the promise and breakthroughs of biological therapies, including immunotherapy, for patients with cancer. SITC is the world's leading member society of medical professionals dedicated to advancing cancer immunotherapy through its initiatives, educational sessions, and collaborative endeavors. The society has become THE forum for innovative discussions in the field.

The Journal of Allergy and Clinical Immunology publishes high-impact, cutting-edge clinical and translational research papers for allergists, immunologists, dermatologists, gastroenterologists, and other physicians and researchers interested in allergic diseases and clinical immunology. Articles cover such topics as asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases, and include clinical trials and mechanistic studies that report on novel therapies, insights into underlying mechanisms, and other discoveries that will inform our understanding of these diseases and ultimately improve the diagnosis and management of patients. With an impact factor of 12.047, the journal ranks 1st of 23 in the Allergy category and 7th of 135 in the Immunology category in the 2013 Journal Citation Reports®, published by Thomson Reuters. The Journal of Allergy and Clinical Immunology is also recommended for initial purchase in the Brandon-Hill study, Selected List of Books and Journals for the Small Medical Library.

Aims and ScopeJACI: In Practice covers the spectrum of conditions treated by allergist-immunologists in their practices. The emphasis of the journal is on information that is practical for clinicians-material that can be used in everyday practice or will help in acquiring new knowledge or skills that can be directly applied to patients. A major goal of JACI: In Practice is to provide our readers with a high level of evidence to support their clinical decisions in diagnosis and management. Content All JACI: In Practice content is peer-reviewed. The journal welcomes original research articles that fit into the above scope. For each original article, a highlight box indicates what is already known about this subject, what this study adds, and how the new information impacts current management guidelines. Shorter original research and instructive case reports are presented as Clinical Communications. "Images in Allergy" submissions that consist of clinical pictures (e.g., X-rays, CT scans, biopsies, allergens, endoscopic visualizations of the airway, eruptions, etc.) and impart important clinical information are also included. In addition, JACI: In Practice features various types of review articles that will primarily be invited by the editors. Many of these will offer CME. The original and review articles are supplemented by Editorials, AAAAI Practice Papers, and a regular Ask the Expert column.

Journal of Asthma & Allergy Educators (JAAE) is a peer-reviewed bi-monthly journal for asthma and allergy management and patient education. JAAE publishes original articles that relate to aspects of patient care and education, clinical practice and/or research, and the multidisciplinary profession of asthma and allergy education.

The Journal of Autoimmunity publishes papers related to the diverse aspects of autoimmunity: the mechanism of self-recognition, regulation of autoimmune responses, experimental autoimmune diseases, diagnostic autoantibody tests, and the epidemiology, pathophysiology, and treatment of autoimmune diseases. Special, but not exclusive, attention will be given to papers dealing with genetic, molecular biology, and cellular aspects of the discipline.Research Areas Include:• Underlying mechanisms of autoimmunity• Immunologic• Molecular• Cellular• Genetic• VirologicAreas of Clinical Interest:• Rheumatology• Dermatology• Endocrinology• Nephrology• Haematology• ImmunopharmacologySpecial issues:Suggestions for special issue topics and guest editors can be sent to Deirdre Dunne, d.dunne@elsevier.comBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The Journal of Clinical Immunology is an international journal that helps researchers and academic clinicians keep current on investigative basic immunology and diseases related to the immune system. This well-established journal publishes articles on basic, translational, and clinical studies in all aspects of immunology, including animal models of human diseases.

Since its inception in 1896, The Journal of Experimental Medicine (JEM) has published papers on the physiological, pathological, and molecular mechanisms that encompass the host response to disease. The journal prioritizes studies on intact organisms and has made a commitment to publishing studies on human subjects.JEM originsThe JEM was founded in 1896 at the Johns Hopkins School of Medicine by William Welch, the school’s founder and also the first president of the Board of Scientific Directors of the Rockefeller Institute. From its inception, Welch edited the journal by himself—even editing manuscripts while attending baseball games—and he eventually found that it placed too heavy a burden on his time. By March 1902, the editorial burden became too great for Welch, who stopped publishing papers and began stockpiling manuscripts and unanswered correspondence in his office, explaining the conspicuous absence of published papers from 1902 to 1904 (see JEM Archives).In October 1902, Welch appealed to the board of The Rockefeller Institute to take over the journal. The transfer of ownership and publication responsibilities required the physical transfer of manuscripts from Welch’s office, which fell to the director of The Rockefeller Institute, Simon Flexner, who carried the abandoned manuscripts from Baltimore to New York in a suitcase.The first issue of the JEM published by The Rockefeller Institute appeared in February 1905, with Flexner serving as editor, and the journal has been published regularly since then. Although the journal was adopted by The Rockefeller Institute as a venue for publication of the Institute’s own research, it also accepted submissions from outside. Even in the early years, more than half of the papers published in the journal came from external labs. .

The Journal of Global Antimicrobial Resistance (JGAR) is a quarterly online journal run by an international Editorial Board that focuses on the global spread of antibiotic-resistant microbes. The Journal aims to track the resistance threat worldwide and to give a comprehensive view of how infectious disease experts are challenging the problem.Featuring peer-reviewed and up to date articles, reviews and short notes JGAR will cover the topical aspects of antimicrobial resistance proposing themes on:resistance mechanisms and gene transfer;antibacterial, antiviral, antifungal and antiparasitic resistance;microbiological and clinical studies stewardship;resistance to disinfectants;microbicides;antimicrobial resistance testing detection and diagnostic;PK/PD and resistancesurveillance studies of resistant pathogens affecting humans at the global level, isolated from different hosts and environments.

The Journal of Immunoassay & Immunochemistry is an international forum for rapid dissemination of research results and methodologies dealing with all aspects of immunoassay and immunochemistry, as well as selected aspects of immunology. They include receptor assay, enzyme-linked immunosorbent assay (ELISA) in all of its embodiments, ligand-based assays, biological markers of ligand-receptor interaction, in vivo and in vitro diagnostic reagents and techniques, diagnosis of AIDS, point-of-care testing, clinical immunology, antibody isolation and purification, and others. Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.